Drugs / Guilingji Capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05320536 | Dec 2021 → Jun 2022 | oligospermia | Jinling Hospital, China | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Guilingji Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05320536 ↗ |
| Route | Oral | “This medicine is capsule medicine, take method is oral.” NCT05320536 ↗ |